Controversy of soluble urokinase-type plasminogen activator receptor in gastrointestinal cancer

Basic & Clinical Medicine ›› 2017, Vol. 37 ›› Issue (3): 415-418.

Controversy of soluble urokinase-type plasminogen activator receptor in gastrointestinal cancer

Received:2016-03-28 Revised:2016-05-31 Online:2017-03-05 Published:2017-02-23

Abstract

Abstract: Soluble urokinase- type plasminogen activator receptor (suPAR) is the soluble form of urokinase- type plasminogen activator receptor (uPAR). Besides being a new biomarker of inflammation, suPAR plays an important role in the growth, development, invasion and metastasis of gastrointestinal cancer. Recent research suggests that suPAR has significant value in the molecular diagnosis of incipient tumors, monitoring of the therapeutic response and further development of the molecular targeted new agents.

Key words: suPAR, cancer, prognosis, biomarker

[1]	QU Haixin, LIANG Junxia, YUAN Erwei, GAO Hongbo, KUI Xiaohua, GUO Weiping. Levels of TLR4, MIF, IL-1β in umbilical cord blood of children with neonatal respiratory distress syndrome and their relationship with prognosis [J]. Basic & Clinical Medicine, 2026, 46(1): 109-113.
[2]	SUN Yingchun, LI Jianjun, YANG Zaibo, YAN Junhui, LIU Yushuo. Level of serum CHI3L1 and sFlt-1 is correlated with disease severity and prognosis of patients with IgA nephropathy [J]. Basic & Clinical Medicine, 2026, 46(1): 22-27.
[3]	LU Wei, WANG Yanmin, LIU Bingchen, TAO Xin, WANG Shipeng, CAO Qiuye. Berberine enhances the chemotherapy sensitivity of prostate cancer cell line 22RV1 to docetaxel [J]. Basic & Clinical Medicine, 2026, 46(1): 39-45.
[4]	LI Binfeng, LYU Fayou, YI Huijun, LYU Lyu. Advances in the mechanism of action of the ring finger proteins family in breast cancer [J]. Basic & Clinical Medicine, 2026, 46(1): 124-128.
[5]	WANG Yangyang, LIU Yang, ZHAO Han, WANG Wei. Current applications and implications of Comprehensive Geriatric Assessment in elderly cancer patients [J]. Basic & Clinical Medicine, 2025, 45(9): 1132-1138.
[6]	WANG Qiumei, LI Xiaoyuan, KANG Lin, SUN Xiaohong, LI Hailong, DUAN Yanping, LIU Ying, GUAN Mei, ZHAO Lin. Consensus recommendation on Comprehensive Geriatric Assessment for elderly cancer patients from Peking Union Medical College Hospital [J]. Basic & Clinical Medicine, 2025, 45(9): 1122-1131.
[7]	CUI Xinyue, HAN Shasha. Role of hydrogen sulfide in asthma [J]. Basic & Clinical Medicine, 2025, 45(9): 1239-1242.
[8]	KANG Lei, ZHU Junlan. Molecular mechanisms of selenium binding protein 1 expression regulation in cancer cells [J]. Basic & Clinical Medicine, 2025, 45(9): 1224-1228.
[9]	WEI Xinwen, WEN Xiaojun, FAN Zhaoqiang, LAO Xifeng, ZHANG Luqing, ZHONG Ming. CircAPLP2 inhibits proliferation, migration and invasion of human colorectal cancer cell lines through regulating miR-455-3p/STMN1 axis [J]. Basic & Clinical Medicine, 2025, 45(9): 1208-1214.
[10]	AN Xin, JIA Lin, Mawusumu·MAMUT, HUANG Zhipeng, KahrimanI·SLAM, Rexiati·REHEMAN, Hairila·WULAMU, Kerbanjiang·ABULIKIM, Jesur·BATUR. Effects of ANGPT1 on proliferation,invasion and angiogenesis of mouse prostate cancer cell line RM-1 [J]. Basic & Clinical Medicine, 2025, 45(9): 1165-1172.
[11]	WEI Jing, SUN Wei. Clinical applications of urine proteome based on mass spectrometry [J]. Basic & Clinical Medicine, 2025, 45(8): 982-991.
[12]	CHEN Lingyun, CHEN Wensong, SUN Qinqiang, ZI Jin. Progress in urinary metabolomics research technologies and applications in cancer diagnosis [J]. Basic & Clinical Medicine, 2025, 45(8): 999-1009.
[13]	ZOU Qingbo, ZHANG Guochen, PAN Changjing. Gypenoside inhibits the proliferation, migration and invasion of prostate cancer cell line PC-3 [J]. Basic & Clinical Medicine, 2025, 45(8): 1059-1065.
[14]	HUANG Qianqian, JIA Yufang, YU Huajun,CHEN Rongrong,CHEN Lili, WU Jun, ZHANG Haitao. Stable knockout of ACSS3 in lung cancer cell line using CRISPR/Cas 9 technology [J]. Basic & Clinical Medicine, 2025, 45(8): 1016-1021.
[15]	JIA Chunliang, LIANG Lei, LI Hansong, WANG Jian, ZHANG Lei, LI Qingke, YAO Yuan. Scutellarin inhibits proliferation and migration of human gastric cancer cell line MGC803 [J]. Basic & Clinical Medicine, 2025, 45(8): 1048-1053.

Controversy of soluble urokinase-type plasminogen activator receptor in gastrointestinal cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments